Table 2.
Outcome of Patients
| Efficacy Index | Anlotinib+S1 | Anlotinib | Test Value | P value |
|---|---|---|---|---|
| PR | 8 | 4 | ||
| SD | 22 | 14 | ||
| PD | 10 | 12 | ||
| ORR | 20.0% | 10.0% | 0.536 | 0.464 |
| DCR | 75.0% | 60.0% | 1.790 | 0.181 |
| PFS | 3.87±0.29 | 3.00±0.24 | 6.511 | 0. 11 |
| OS | 8.07±0.56 | 6.17±0.42 | 5.248 | 0.022 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.